Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 2yfx | VGH | ALK tyrosine kinase receptor | 2.7.10.1 |
| PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
|---|---|---|---|---|---|
| 2yfx | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 1.000 | |
| 4anq | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.723 | |
| 5aaa | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.719 | |
| 4ans | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.717 | |
| 5aac | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.660 | |
| 4fob | 0US | ALK tyrosine kinase receptor | 2.7.10.1 | 0.563 | |
| 5aab | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.555 | |
| 2xp2 | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.539 | |
| 4cd0 | AWJ | ALK tyrosine kinase receptor | 2.7.10.1 | 0.521 | |
| 2yit | YIT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.520 | |
| 2ycq | UPX | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.517 | |
| 3w2o | 03P | Epidermal growth factor receptor | 2.7.10.1 | 0.517 | |
| 4bdc | ODH | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.517 | |
| 2c6e | HPM | Aurora kinase A | 2.7.11.1 | 0.516 | |
| 4mcv | 29K | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.515 | |
| 2ycr | HCW | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.510 | |
| 3f5p | 741 | Insulin-like growth factor 1 receptor | 2.7.10.1 | 0.509 | |
| 2xk9 | XK9 | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.508 | |
| 4yzc | STU | Serine/threonine-protein kinase/endoribonuclease IRE1 | 2.7.11.1 | 0.508 | |
| 4b99 | R4L | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.507 | |
| 2w0j | ZAT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.506 | |
| 3uvq | FS8 | Mitogen-activated protein kinase 14 | / | 0.505 | |
| 4bdd | Z0O | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.505 | |
| 3a7h | ATP | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.504 | |
| 4dgg | I76 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.504 | |
| 4fic | 0UL | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.504 | |
| 4g1w | G1W | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.501 | |
| 4mxy | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.501 | |
| 4mxz | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.501 | |
| 4nka | 2K7 | Fibroblast growth factor receptor 1 | / | 0.501 | |
| 3vjo | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.499 | |
| 4id7 | 1G0 | Activated CDC42 kinase 1 | / | 0.499 | |
| 2w7x | D1A | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.498 | |
| 2xb7 | GUI | ALK tyrosine kinase receptor | 2.7.10.1 | 0.498 | |
| 2qoq | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.496 | |
| 2yir | YIR | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.495 | |
| 4bdf | H3R | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.495 | |
| 2j0m | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.492 | |
| 1i44 | ACP | Insulin receptor | 2.7.10.1 | 0.491 | |
| 4qml | ANP | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.491 | |
| 2qo7 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.490 | |
| 3cjg | KIM | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.490 | |
| 3vs7 | KS1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.490 | |
| 4gk4 | L90 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.490 | |
| 2ijm | ATP | Focal adhesion kinase 1 | 2.7.10.2 | 0.487 | |
| 2itn | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.486 | |
| 4bdh | WVI | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.486 | |
| 4nks | 2M2 | Fibroblast growth factor receptor 1 | / | 0.486 | |
| 2hen | ADP | Ephrin type-B receptor 2 | 2.7.10.1 | 0.485 | |
| 3cbl | STU | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.484 | |
| 4mxx | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.484 | |
| 4c62 | XWW | Tyrosine-protein kinase JAK2 | / | 0.483 | |
| 3lct | ADP | ALK tyrosine kinase receptor | 2.7.10.1 | 0.482 | |
| 4mf0 | 29Z | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.482 | |
| 1qpj | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.481 | |
| 2vrx | 447 | Aurora kinase B-A | 2.7.11.1 | 0.481 | |
| 3v8w | 0G2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.481 | |
| 1jqh | ANP | Insulin-like growth factor 1 receptor | 2.7.10.1 | 0.480 | |
| 2j0l | ANP | Focal adhesion kinase 1 | 2.7.10.2 | 0.480 | |
| 3b2w | 9NH | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.480 | |
| 4hyu | 1BK | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.480 | |
| 4qo9 | 627 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.480 | |
| 1u54 | ACP | Activated CDC42 kinase 1 | / | 0.479 | |
| 2qo9 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.478 | |
| 3op5 | REB | Serine/threonine-protein kinase VRK1 | 2.7.11.1 | 0.478 | |
| 4bdb | ODO | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.478 | |
| 4fr4 | STU | Serine/threonine-protein kinase 32A | 2.7.11.1 | 0.478 | |
| 4joa | 3DK | ALK tyrosine kinase receptor | 2.7.10.1 | 0.478 | |
| 4o0u | ADN | Aurora kinase A | 2.7.11.1 | 0.478 | |
| 1qcf | PP1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.477 | |
| 2vwu | 7X1 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.477 | |
| 3vs6 | VSH | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.477 | |
| 4ccu | AWF | ALK tyrosine kinase receptor | 2.7.10.1 | 0.477 | |
| 4i22 | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.477 | |
| 2etm | 7PY | Focal adhesion kinase 1 | 2.7.10.2 | 0.476 | |
| 3vrz | VRZ | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.476 | |
| 4gt3 | ATP | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.476 | |
| 4gmy | 0X5 | Tyrosine-protein kinase JAK2 | / | 0.475 | |
| 2hk5 | 1BM | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.474 | |
| 4bf2 | STU | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.474 | |
| 4gk3 | L87 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.474 | |
| 4jia | 1K3 | Tyrosine-protein kinase JAK2 | / | 0.474 | |
| 2ghm | LIC | Mitogen-activated protein kinase 14 | / | 0.473 | |
| 2itt | AEE | Epidermal growth factor receptor | 2.7.10.1 | 0.473 | |
| 2ycs | NXP | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.473 | |
| 3cd3 | STU | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.473 | |
| 4awi | AQ2 | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.473 | |
| 2of4 | 979 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.472 | |
| 4bdg | P3J | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.472 | |
| 3vs2 | VSB | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.471 | |
| 4dfn | 0K1 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.471 | |
| 2hxl | 422 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.470 | |
| 4i23 | 1C9 | Epidermal growth factor receptor | 2.7.10.1 | 0.470 | |
| 2yiq | YIQ | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.468 | |
| 2xa4 | AZ5 | Tyrosine-protein kinase JAK2 | / | 0.467 | |
| 3lcd | BDY | Macrophage colony-stimulating factor 1 receptor | 2.7.10.1 | 0.467 | |
| 4ks8 | B49 | Serine/threonine-protein kinase PAK 6 | 2.7.11.1 | 0.467 | |
| 1okz | UCN | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.466 | |
| 2xvd | AS6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.466 | |
| 2y7j | B49 | Phosphorylase b kinase gamma catalytic chain, liver/testis isoform | 2.7.11.19 | 0.466 | |
| 2itu | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.465 | |
| 3bkb | STU | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.465 | |
| 3f69 | XDR | Serine/threonine-protein kinase PknB | 2.7.11.1 | 0.465 | |
| 3vry | B43 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.465 | |
| 3zew | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.465 | |
| 4l7s | G7K | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.465 | |
| 4y93 | 746 | Tyrosine-protein kinase | / | 0.465 | |
| 2qoc | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.464 | |
| 2vgo | AD5 | Aurora kinase B-A | 2.7.11.1 | 0.464 | |
| 3cok | ANP | Serine/threonine-protein kinase PLK4 | 2.7.11.21 | 0.464 | |
| 3e5a | VX6 | Aurora kinase A | 2.7.11.1 | 0.464 | |
| 3mpa | SB2 | Mitogen-activated protein kinase 14 | / | 0.464 | |
| 3w2s | W2R | Epidermal growth factor receptor | 2.7.10.1 | 0.464 | |
| 4jbq | VX6 | Aurora kinase A | 2.7.11.1 | 0.464 | |
| 5d12 | G97 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.464 | |
| 2bfy | H1N | Aurora kinase B-A | 2.7.11.1 | 0.463 | |
| 4f63 | 0S7 | Fibroblast growth factor receptor 1 | / | 0.463 | |
| 4fod | 0UV | ALK tyrosine kinase receptor | 2.7.10.1 | 0.463 | |
| 2e9n | 76A | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.462 | |
| 2h8h | H8H | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.462 | |
| 2wqe | ADP | Aurora kinase A | 2.7.11.1 | 0.462 | |
| 2x9f | X9F | Ephrin type-B receptor 4 | 2.7.10.1 | 0.462 | |
| 4bdi | HAU | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.462 | |
| 4eym | 0RX | Mitogen-activated protein kinase 13 | 2.7.11.24 | 0.462 | |
| 4nk9 | 2K5 | Fibroblast growth factor receptor 1 | / | 0.462 | |
| 4wkq | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.462 | |
| 2itq | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.461 | |
| 2py3 | ACP | Fibroblast growth factor receptor 2 | / | 0.461 | |
| 4ccb | OFG | ALK tyrosine kinase receptor | 2.7.10.1 | 0.461 | |
| 1v9a | SAH | Uncharacterized protein | / | 0.460 | |
| 4f64 | 0S8 | Fibroblast growth factor receptor 1 | / | 0.460 | |
| 4j97 | ACP | Fibroblast growth factor receptor 2 | / | 0.460 | |
| 2biy | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.459 | |
| 2itz | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.459 | |
| 2pwl | ACP | Fibroblast growth factor receptor 2 | / | 0.459 | |
| 2ydi | YDI | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.459 | |
| 3hrf | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.459 | |
| 4ic7 | ANP | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.459 | |
| 4y95 | 746 | Tyrosine-protein kinase | / | 0.459 | |
| 1ad5 | ANP | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.458 | |
| 2ijm | ADP | Focal adhesion kinase 1 | 2.7.10.2 | 0.458 | |
| 2ivu | ZD6 | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.458 | |
| 2j7t | 274 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.458 | |
| 3vid | 4TT | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.458 | |
| 4bc6 | XZN | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.458 | |
| 4c61 | LMM | Tyrosine-protein kinase JAK2 | / | 0.458 | |
| 4jq8 | KJ8 | Epidermal growth factor receptor | 2.7.10.1 | 0.458 | |
| 4riy | ADP | Epidermal growth factor receptor | 2.7.10.1 | 0.458 | |
| 4xx9 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.458 | |
| 2bdf | 24A | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.457 | |
| 2vgp | AD6 | Aurora kinase B-A | 2.7.11.1 | 0.457 | |
| 3l8p | 0CE | Angiopoietin-1 receptor | 2.7.10.1 | 0.457 | |
| 4k8a | K8A | Focal adhesion kinase 1 | 2.7.10.2 | 0.457 | |
| 4mxo | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.457 | |
| 1qpd | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.456 | |
| 1yol | S03 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.456 | |
| 2phk | ATP | Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform | 2.7.11.19 | 0.456 | |
| 3a62 | STU | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.456 | |
| 4ma6 | 28E | Ara h 8 allergen | / | 0.456 | |
| 4nxv | GDP | Mitochondrial dynamics protein MID51 | / | 0.456 | |
| 2hog | 710 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.455 | |
| 3w33 | W19 | Epidermal growth factor receptor | 2.7.10.1 | 0.455 | |
| 1mqb | ANP | Ephrin type-A receptor 2 | 2.7.10.1 | 0.454 | |
| 3ac3 | KSH | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.454 | |
| 3b8r | 887 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.454 | |
| 3gub | GUB | Death-associated protein kinase 1 | 2.7.11.1 | 0.454 | |
| 3t8o | ATP | Rhodopsin kinase | / | 0.454 | |
| 3tti | KBI | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.454 | |
| 2itw | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.453 | |
| 3ad6 | KSC | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.453 | |
| 3qlg | 1N1 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.453 | |
| 3w1f | 1O5 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.453 | |
| 4foc | 0UU | ALK tyrosine kinase receptor | 2.7.10.1 | 0.453 | |
| 5e8x | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.453 | |
| 1uvr | BI8 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.452 | |
| 3lij | ANP | Calcium/calmodulin dependent protein kinase with a kinase domain and 4 calmodulin like EF hands | / | 0.452 | |
| 3vqu | O22 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.452 | |
| 4a06 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.452 | |
| 4aoj | V4Z | High affinity nerve growth factor receptor | 2.7.10.1 | 0.452 | |
| 4ieb | ANP | Calmodulin-domain protein kinase 1 | / | 0.452 | |
| 4xey | 1N1 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.452 | |
| 4xli | 1N1 | Abelson tyrosine-protein kinase 2 | 2.7.10.2 | 0.452 | |
| 2itv | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.451 | |
| 3pxk | PXK | Focal adhesion kinase 1 | 2.7.10.2 | 0.451 | |
| 4ftk | H9K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.451 | |
| 4yhj | AN2 | G protein-coupled receptor kinase 4 | 2.7.11.16 | 0.451 | |
| 5l8l | ADP | Aurora kinase A | 2.7.11.1 | 0.451 | |
| 2xm9 | LWH | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.450 | |
| 2zva | 1N1 | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.450 | |
| 3fko | FKO | Mitogen-activated protein kinase 14 | / | 0.450 | |
| 4bib | IEO | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.450 | |
| 4c4i | X20 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.450 | |
| 4qmn | DB8 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.450 | |
| 2wmu | ZYU | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.449 | |
| 3gc9 | B45 | Mitogen-activated protein kinase 11 | 2.7.11.24 | 0.449 | |
| 4wbo | ANW | Rhodopsin kinase | / | 0.449 | |
| 2j0j | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.448 | |
| 4rrv | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.448 | |
| 2v7a | 627 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.447 | |
| 2ycf | YCF | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.447 | |
| 3ttj | JBI | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.447 | |
| 3w18 | N13 | Aurora kinase A | 2.7.11.1 | 0.447 | |
| 4b8m | VX6 | Aurora kinase B-A | 2.7.11.1 | 0.447 | |
| 4btk | DTQ | Tau-tubulin kinase 1 | 2.7.11.1 | 0.447 | |
| 4fl1 | ANP | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.447 | |
| 1uu8 | BI1 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.446 | |
| 2cmw | OLP | Casein kinase I isoform gamma-1 | 2.7.11.1 | 0.446 | |
| 2p2h | 994 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.446 | |
| 2wmq | ZYQ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.446 | |
| 3el8 | PD5 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.446 | |
| 3sc1 | 3S1 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.446 | |
| 3ue4 | DB8 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.446 | |
| 4aot | GW8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.446 | |
| 4f4p | 0SB | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.446 | |
| 4fti | H7K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.446 | |
| 4jrv | KJV | Epidermal growth factor receptor | 2.7.10.1 | 0.446 | |
| 5dr9 | SKE | Aurora kinase A | 2.7.11.1 | 0.446 | |
| 3ama | SKE | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.445 | |
| 3emg | 685 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.445 | |
| 3i60 | E86 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.445 | |
| 3vs5 | VSG | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.445 | |
| 4lop | SB4 | Mitogen-activated protein kinase 14 | / | 0.445 | |
| 1jpa | ANP | Ephrin type-B receptor 2 | 2.7.10.1 | 0.444 | |
| 3nun | JMZ | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.444 | |
| 4bi0 | Z0W | Dual specificity protein kinase TTK | 2.7.12.1 | 0.444 | |
| 4dit | 0KD | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.444 | |
| 4g6n | EK0 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.444 | |
| 4j95 | ACP | Fibroblast growth factor receptor 2 | / | 0.444 | |
| 3hl7 | I47 | Mitogen-activated protein kinase 14 | / | 0.443 | |
| 4ct1 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.443 | |
| 4k11 | 0J9 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.443 | |
| 4qmt | H1N | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.443 | |
| 5awm | ANP | Stress-activated protein kinase JNK | 2.7.11.24 | 0.443 | |
| 2c0t | L3G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.442 | |
| 2j0k | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.442 | |
| 2r7b | 253 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.442 | |
| 2wmx | ZY6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.442 | |
| 2wtc | VGM | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.442 | |
| 2ym6 | YM6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.442 | |
| 3aox | EMH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.442 | |
| 3c4x | ATP | Rhodopsin kinase | / | 0.442 | |
| 4erw | STU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.442 | |
| 4fsr | HKC | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.442 | |
| 4hvh | 19R | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.442 | |
| 1szm | BI4 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.441 | |
| 3q4z | ANP | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.441 | |
| 3vs4 | VSF | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.441 | |
| 4ftm | 1HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.441 | |
| 4ftt | 6HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.441 | |
| 4g2f | C07 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.441 | |
| 4hys | 1BJ | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.441 | |
| 4uya | AGS | Mitogen-activated protein kinase kinase kinase 21 | 2.7.11.25 | 0.441 | |
| 4w9w | YDJ | BMP-2-inducible protein kinase | 2.7.11.1 | 0.441 | |
| 5e8w | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.441 | |
| 2hxq | 373 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.440 | |
| 2itp | AEE | Epidermal growth factor receptor | 2.7.10.1 | 0.440 | |
| 2of2 | 547 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.440 | |
| 2zmd | 537 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.440 | |
| 3vjn | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.440 | |
| 3vs0 | VS0 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.440 | |
| 3zep | 1NX | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.440 |